These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28618932)

  • 21. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment.
    Frediani JN; Fabbri M
    Mol Cancer; 2016 May; 15(1):42. PubMed ID: 27231010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The host-tumor interface in B-cell non-Hodgkin lymphoma: a new world to investigate.
    Rachinel N; Salles G
    Curr Hematol Malig Rep; 2009 Oct; 4(4):196-201. PubMed ID: 20425408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomes: Powerful weapon for cancer nano-immunoengineering.
    Pi YN; Xia BR; Jin MZ; Jin WL; Lou G
    Biochem Pharmacol; 2021 Apr; 186():114487. PubMed ID: 33647264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
    Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
    Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the tumor microenvironment in mature B-cell lymphoid malignancies.
    Fowler NH; Cheah CY; Gascoyne RD; Gribben J; Neelapu SS; Ghia P; Bollard C; Ansell S; Curran M; Wilson WH; O'Brien S; Grant C; Little R; Zenz T; Nastoupil LJ; Dunleavy K
    Haematologica; 2016 May; 101(5):531-40. PubMed ID: 27132279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy.
    Wang S; Shi Y
    Int J Nanomedicine; 2022; 17():6527-6550. PubMed ID: 36575698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor microenvironment: The culprit for ovarian cancer metastasis?
    Luo Z; Wang Q; Lau WB; Lau B; Xu L; Zhao L; Yang H; Feng M; Xuan Y; Yang Y; Lei L; Wang C; Yi T; Zhao X; Wei Y; Zhou S
    Cancer Lett; 2016 Jul; 377(2):174-82. PubMed ID: 27131957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-mediated therapeutic resistance in breast cancer.
    Tan C; Hu W; He Y; Zhang Y; Zhang G; Xu Y; Tang J
    Cytokine; 2018 Aug; 108():151-159. PubMed ID: 29609137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted remodeling of breast cancer and immune cell homing niches by exosomal integrins.
    Myint PK; Park EJ; Gaowa A; Kawamoto E; Shimaoka M
    Diagn Pathol; 2020 Apr; 15(1):38. PubMed ID: 32305065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the microenvironment across histological subtypes of NHL.
    Tarte K
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):610-617. PubMed ID: 29222311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Biology of Cancer Exosomes: Insights and New Perspectives.
    Ruivo CF; Adem B; Silva M; Melo SA
    Cancer Res; 2017 Dec; 77(23):6480-6488. PubMed ID: 29162616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics.
    Challagundla KB; Fanini F; Vannini I; Wise P; Murtadha M; Malinconico L; Cimmino A; Fabbri M
    Expert Rev Mol Diagn; 2014 Jun; 14(5):565-74. PubMed ID: 24844135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Going live with tumor exosomes and microvesicles.
    Hyenne V; Lefebvre O; Goetz JG
    Cell Adh Migr; 2017 Mar; 11(2):173-186. PubMed ID: 28135898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models.
    Suetsugu A; Honma K; Saji S; Moriwaki H; Ochiya T; Hoffman RM
    Adv Drug Deliv Rev; 2013 Mar; 65(3):383-90. PubMed ID: 22921594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes in cancer: small particle, big player.
    Zhang X; Yuan X; Shi H; Wu L; Qian H; Xu W
    J Hematol Oncol; 2015 Jul; 8():83. PubMed ID: 26156517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.
    Taylor DD; Gercel-Taylor C
    Semin Immunopathol; 2011 Sep; 33(5):441-54. PubMed ID: 21688197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of exosomes on pre-metastatic niche formation in tumors.
    Guo Y; Ji X; Liu J; Fan D; Zhou Q; Chen C; Wang W; Wang G; Wang H; Yuan W; Ji Z; Sun Z
    Mol Cancer; 2019 Mar; 18(1):39. PubMed ID: 30857545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of tumor escape from the immune system: adenosine-producing Treg, exosomes and tumor-associated TLRs.
    Whiteside TL; Mandapathil M; Szczepanski M; Szajnik M
    Bull Cancer; 2011 Feb; 98(2):E25-31. PubMed ID: 21339097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy.
    Fatima F; Nawaz M
    Chin J Cancer; 2015 Sep; 34(12):541-53. PubMed ID: 26369565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances on the role of tumor exosomes in immunosuppression and disease progression.
    Filipazzi P; Bürdek M; Villa A; Rivoltini L; Huber V
    Semin Cancer Biol; 2012 Aug; 22(4):342-9. PubMed ID: 22369922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.